Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Transition and Transfer of Congenital Heart Disease Care From Pediatrics to Adulthood

30 de junio de 2026 actualizado por: Ottawa Heart Institute Research Corporation

Transition and Transfer of Congenital Heart Disease Care From Pediatrics to Adulthood.

Adults with congenital heart disease (CHD) are a growing patient population in need of ongoing specialized care. Lapses in appropriate transition and transfer processes from childhood to adulthood in CHD care can lead to loss in follow up, late detection of new or evolving cardiac complications and negative patient outcomes. Therefore, it is vital that a robust transition and transfer process is established. Through a retrospective study completed recently at the University of Ottawa Heart Institute (UOHI) we have shown that the average wait time to be assessed by an adult congenital heart disease (ACHD) specialist is about 10 months and within this wait period 1 in 8 ACHD patients have a decline in their health.

The goal of this study is to specifically reduce negative patient outcomes during this wait period. We aim to achieve this by (i) establishing a program to ensure early detection of patients at risk of deterioration and (ii) providing additional support to these patients. The program is designed to have a multipronged approach including tools to disseminate concise patient specific information among care providers, maintain open line of communication with patients on the waitlist and promote patient education.

We plan to improve our transition care by creating a multi-pronged transfer program specifically for patients on the wait list composed of a nurse check in, creation of a diagnosis summary, education day and combined pediatric cardiology/ACHD handover videocall (described below). This program is planned as part of our care pathway and will be offered to all patients on the wait list. We intend to document the efficacy of this transition program to improve transition care by assessing patient reported outcomes and clinical outcomes of the patients who consent to complete additional questionnaires.

The multi-pronged program will include the following:

  1. ACHD nurse check-in (patient check-in via phone call or zoom from the ACHD nurse within 1 month of receiving referral) - allows early establishment of clinical relationship with the patient, screen for risk factors for deterioration and provision of ACHD clinic contact information to enable open line of communication. Patients considered at risk for deterioration on the wait-list based on this check-in conversation will be triaged for a more urgent first consult at the ACHD clinic.
  2. Quick glance diagnosis summary (Electronic on Epic MyChart) - will be created during nurse check in and will be used to disseminate concise patient specific information among health care workers and acts as a reference for the patients.
  3. Organization of an ACHD patient education day (half day hybrid event every 6 months) - allows formal introduction to the ACHD team, provides information session on ACHD care and lowers patients' threshold to inform the ACHD team in case of clinical deterioration.
  4. Combined pediatric cardiology and ACHD handover video call at time of transfer - allows effective and efficient handover of patient care from pediatric to adult care and facilitates the coordination of care during the transfer period.

These four components of the program work together to provide tools to disseminate concise patient specific information among care providers, maintain open line of communication with patients on the waitlist and promote patient education.

Descripción general del estudio

Estado

Reclutamiento

Intervención / Tratamiento

Descripción detallada

This is a prospective quality improvement study, investigating the effectiveness of a structured multi-pronged transfer program on clinical outcomes and patient-reported outcomes. This program is planned as part of our care pathway and will be offered to all patients on the wait list. Charts of all patients enrolled in this transfer program will be reviewed to assess clinical outcomes. Further voluntary study participation will include an additional survey to assess patient reported outcomes. The patients willing to complete the survey will be consented verbally by the ACHD nurse. The surveys then will be delivered by the nurse using phone or zoom platform to those consenting to participate. Data collection from chart review and surveys will be performed by a research coordinator (KM).

There are 4 components of the transfer program. Groups of patients will be staggered so that the first 50 patients receive 1+2, next 50 patients receive 1+2+3 and the rest of the patients receive 1+2+3+4 as listed below:

  1. ACHD nurse check-in
  2. Quick glance diagnosis summary
  3. ACHD patient education day
  4. Combined pediatric cardiology and ACHD handover video call at time of transfer

Individual component described below:

1) ACHD nurse check-in via phone or zoom will be completed within 1 month of receiving referral.

  1. Patients referred from CHEO and community will be called by the ACHD nurse within 1 month of receiving the referral as part of the ACHD nurse check-in.
  2. ACHD nurse check-in template will be uploaded to patient chart on Epic. It will include the following (details attached as a separate document):

i. Access to family physician. ii. Assess patient's knowledge on their cardiac condition. iii. Patient' social circumstance. iv. Patient's dental health. v. Patient's lifestyle habits. vi. Any active cardiac symptoms. vii. Need to expedite ACHD cardiologist appointment. If patient meets any of the following criteria, then patient will be flagged as needing expedited cardiologist appointment:

1. Worsening arrhythmias (i.e. new or more frequent/intense symptomatic palpitations or new sustained arrythmias) 2. Decreasing exercise intolerance 3. Change in NYHA class 4. Syncope 5. Exercise induced chest pain 6. Peripheral edema or unexplained weight gain viii. Gage interest in patient education day. c. The nurse will also complete the quick glance diagnosis summary for the patient during this check in which is outlined below.

d. Initial assessment of patient reported outcomes (PROs) will be completed in the form of an additional survey for the patients who consent to participate.

2) Quick glance diagnosis summary will be completed and provided to the patient.

  • This will be completed by the ACHD nurse at the time of the ACHD nurse check in (within 1 month of receiving the referral).
  • This will be created electronically on the patient's Epic chart under letter/ communications section, which can also be accessed by the patients via their MyChart.
  • The content will be reviewed by ACHD specialist to ensure accuracy.
  • The components of the quick glance diagnosis summary have been reviewed by our patient partner and deemed helpful.
  • The quick glance diagnosis summary will include (details attached as a separate document):

    • Patient name
    • Date of birth
    • Name of ACHD cardiologist
    • Congenital heart disease diagnosis
    • Main surgical/ percutaneous intervention
    • Cardiac device
    • Previous infective endocarditis/ need for endocarditis prophylaxis.
    • Exercise restriction
    • Need for bubble filters on intravenous lines
    • Anti-coagulation
    • Contraception
    • Alarm symptoms to monitor
    • Recommended vaccines
    • Contact information for ACHD clinic

      3) Organization of patient education day for all patients on the waitlist. This is a half day event. Ideally this event will occur every 6 months and would include both patients referred from CHEO as well as the community. Participation will be documented.

  • The education day will include:

    • Formal introduction to ACHD team including nurses and physicians
    • Tour of UOHI facility including clinic/ echo lab
    • Education session emphasizing need for lifelong follow-up, regular exercise, monitoring of alarm symptoms. Session facilitated by dietitian, social worker, psychologist, physiotherapist
    • Networking
    • Option for in-person and virtual component 4) Combined Pediatric cardiology and ACHD handover video calls.
  • Allows effective and efficient handover of patient care from pediatric to adult care team.
  • Will occur after the patient's last pediatric cardiology appointment. This component of the transfer program cannot be offered to patients referred from the community.

Variables to be collected:

Within the first month of being on the ACHD waitlist the following will be completed for all patients (whether or not consenting to participate in the voluntary survey):

  • Electronic Quick glance diagnosis summary created on Epic MyChart (described above)
  • ACHD nurse check via phone and documented on Epic (described above)

During the 1 month ACHD nurse check in, the following information will be collected in the form of a survey (in addition to the standard ACHD nurse check in template) only from those consenting to participate (details attached separately):

  • Age/ date of birth (mm/yyyy)
  • Sex/gender
  • Ethnicity/ race
  • Socioeconomic status (student/ employed/ unemployed)
  • Access to family physician
  • Knowledge assessment related to CHD
  • Initial patient reported outcomes (PROS):

    • Quality-of-life score on linear analog scale9 during the waiting period
    • Patient Health Questionnaire (PHQ9) score10,11 for depression
    • General Anxiety Disorder (GAD-7) score12,13 for anxiety
    • Satisfaction with life survey score14

At time of first ACHD clinic appointment after completing wait list, the following variables will be collected:

  • From chart review (all patients):

    • Duration on wait list
    • Date of first ACHD clinic appointment
    • Number of non-planned ED visits during the wait period
    • Number of unexpected hospital admissions during the wait period
    • Number of family physician visits related to CHD during the wait period
    • Number of urgent interventions planned.
  • From patient survey (in patients consenting to complete the surveys)

    • Assessment of emotional distress related to wait period
    • Knowledge assessment related to CHD
    • Repeat patient reported outcomes (PROS) collected in the form of surveys:
  • Quality-of-life score on linear analog scale9 during the waiting period
  • Patient Health Questionnaire (PHQ9) score10,11 for depression
  • General Anxiety Disorder (GAD-7) score12,13 for anxiety
  • Satisfaction with life survey score14

Tipo de estudio

De observación

Inscripción (Estimado)

200

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Ontario
      • Ottawa, Ontario, Canadá, K1y4W7
        • Reclutamiento
        • University of Ottawa Heart Institute
        • Contacto:
        • Contacto:
        • Investigador principal:
          • Markus Schwerzmann, MD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Método de muestreo

Muestra no probabilística

Población de estudio

Patients with congenital heart disease (CHD) referred from the pediatric hospital and the community to the University of Ottawa Heart Institute.

Descripción

Inclusion Criteria:

  • All new patients with congenital heart disease referred from the pediatric hospital and the community

Exclusion Criteria:

  • None

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Patients with congenital heart disease referred to the University of Ottawa Heart Institute
We aim to include all the patients referred to the UOHI ACHD program in our multipronged transfer program. This will include patients from the pediatric hospital (CHEO) and community referrals.

There are 4 components of the transfer program. Groups of patients will be staggered so that the first 50 patients receive 1+2, next 50 patients receive 1+2+3 and the rest of the patients receive 1+2+3+4 as listed below:

  1. ACHD nurse check-in
  2. Quick glance diagnosis summary
  3. ACHD patient education day
  4. Combined pediatric cardiology and ACHD handover video call at time of transfer

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Hospitalizations
Periodo de tiempo: 2 years
Number of unexpected hospitalizations related to patient's cardiac condition during the wait period.
2 years
Doctor visits related to cardiac conditions
Periodo de tiempo: 2 years
Number of family physician visits related to patient's cardiac condition during the wait period.
2 years
Unexpected urgent intervention
Periodo de tiempo: 2 years
Number of urgent intervention related to the cardiac conditions during the wait period.
2 years
Emergency Room Visits
Periodo de tiempo: 2 years
Number of non-planned emergency department visits related to patient's cardiac condition during the wait period.
2 years

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Patient Health Questionnaire (PHQ9) score for depression
Periodo de tiempo: 2 years
Patient reported outcomes, scored form 0-27, with higher scores indicating greater severity
2 years
Change in General Anxiety Disorder (GAD-7) score for anxiety
Periodo de tiempo: 2 years
Patient reported outcomes, scored from 0 to 21, with higher scores indicating greater severity.
2 years
Change in Satisfaction With Life Survey (SWLS) score
Periodo de tiempo: 2 years
Patient reported outcomes, scored from 5 to 25, with higher scores indicating greater life satisfaction.
2 years

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de junio de 2024

Finalización primaria (Estimado)

31 de diciembre de 2026

Finalización del estudio (Estimado)

31 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

24 de octubre de 2024

Primero enviado que cumplió con los criterios de control de calidad

8 de mayo de 2026

Publicado por primera vez (Actual)

13 de mayo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

30 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir